Prihlásiť sa Zaregistrujte sa zadarmo

Budúce P/E spoločnosti Starpharma

Aká je hodnota metriky Budúce P/E spoločnosti Starpharma?

Hodnota metriky Budúce P/E spoločnosti Starpharma Holdings Limited je 312.50

Aká je definícia metriky Budúce P/E?



Budúci pomer P/E (Forward price to earnings ratio) vyjadruje pomer súčasnej ceny a odhadovaného zisku na akciu za ďalších 12 mesiacov.

The forward price to earnings ratio is similar to trailing price to earnings ratio but instead of net income uses estimated net earnings over next 12 months. Estimates are typically derived as the mean of those published by a select group of analysts with selection criteria varying. The forward price-to-earnings ratio is a powerful, but limited tool. It allows a quick snapshot of the company’s finances without getting down in the details of an accounting report.

Budúce P/E spoločností v sektore Health Care sektor na ASX v porovnaní so spoločnosťou Starpharma

Čomu sa venuje spoločnosť Starpharma?

Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications worldwide. The company offers VivaGel, a non-antibiotic therapy for the management and prevention of bacterial vaginosis. It also develops VivaGel condom, an antiviral condom; and VIRALEZE, an antiviral nasal spray. In addition, the company develops DEP, a dendrimer drug delivery technology, including DEP docetaxel that is in Phase II clinical trials, DEP cabazitaxel that is in Phase II clinical trial, and DEP irinotecan that is in phase II clinical trials for the treatment of cancer; oncology programs, such as DEP radiopharmaceuticals, DEP HER-2 ADC, and DEP gemcitabine; DEP non-oncology candidates; and DEP AZD0466, which is in Phase I/II clinical trials to treat haematological tumours. The company was founded in 1996 and is headquartered in Abbotsford, Australia.

Firmy s metrikou budúce p/e podobnou spoločnosti Starpharma



  • Hodnota metriky Budúce P/E spoločnosti Westlife Development je 286.57
  • Hodnota metriky Budúce P/E spoločnosti Pay je 294.12
  • Hodnota metriky Budúce P/E spoločnosti HEXO je 294.12
  • Hodnota metriky Budúce P/E spoločnosti InnoCare Pharma je 303.03
  • Hodnota metriky Budúce P/E spoločnosti Coeur Mining je 303.03
  • Hodnota metriky Budúce P/E spoločnosti Equity Commonwealth je 304.22
  • Hodnota metriky Budúce P/E spoločnosti Starpharma je 312.50
  • Hodnota metriky Budúce P/E spoločnosti Gray Television je 313.09
  • Hodnota metriky Budúce P/E spoločnosti MSG Networks je 322.58
  • Hodnota metriky Budúce P/E spoločnosti NanoXplore je 322.58
  • Hodnota metriky Budúce P/E spoločnosti Cloudflare Inc je 324.93
  • Hodnota metriky Budúce P/E spoločnosti Endeavour Silver je 333.33
  • Hodnota metriky Budúce P/E spoločnosti Nanosonics je 333.33